These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20592366)

  • 41. Thyroid function in benign and malignant breast disease.
    Vorherr H
    Eur J Cancer Clin Oncol; 1987 Mar; 23(3):255-7. PubMed ID: 3297715
    [No Abstract]   [Full Text] [Related]  

  • 42. Thyroid supplementation for hypothyroidism. An latrogenic cause of breast cancer?
    Mustacchi P; Greenspan F
    JAMA; 1977 Apr; 237(14):1446-7. PubMed ID: 576635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of thyroid function in the prognosis of cancer of the breast].
    MARQUES P; BRU A; ESPINASSE A
    Bull Assoc Fr Etud Cancer; 1959; 46():645-54. PubMed ID: 14421429
    [No Abstract]   [Full Text] [Related]  

  • 44. The thyroid hormone as preventive treatment for metastases of breast and genital cancer in women.
    LOESER AA
    Tokoginecol Pract; 1955 Apr; 14(131):155-64. PubMed ID: 14396901
    [No Abstract]   [Full Text] [Related]  

  • 45. [Combined action of male and thyroid hormones on cancer of the breast and genitals in women].
    LOESER AA
    Gynecol Prat; 1950; 1(3):179-90. PubMed ID: 14802883
    [No Abstract]   [Full Text] [Related]  

  • 46. Endocrinology of breast cancer.
    Vorherr H
    Maturitas; 1987 Aug; 9(2):113-22. PubMed ID: 3309571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Influence of Tumor-Specific Markers in Breast Cancer on Other Blood Parameters.
    Varzaru VB; Eftenoiu AE; Vlad DC; Vlad CS; Moatar AE; Popescu R; Cobec IM
    Life (Basel); 2024 Mar; 14(4):. PubMed ID: 38672729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thyroid hormone for the prevention of postoperative recurrence of carcinoma of the female breast and genitalia; a review of 211 cases in a nine-year study.
    LOESER AA
    J Int Coll Surg; 1958 Mar; 29(3 Pt 1):337-47. PubMed ID: 13539413
    [No Abstract]   [Full Text] [Related]  

  • 49. A new therapy for prevention of post-operative recurrences in genital and breast cancer; a six-years study of prophylactic thyroid treatment.
    LOESER AA
    Br Med J; 1954 Dec; 2(4901):1380-3. PubMed ID: 13209124
    [No Abstract]   [Full Text] [Related]  

  • 50. Thyroid function and breast cancer.
    Thomas BS
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1541-2. PubMed ID: 3595679
    [No Abstract]   [Full Text] [Related]  

  • 51. [Thyroid function in patients with cancer of the breast].
    Bignazzi A; D'Amico P; Veronesi U
    Tumori; 1965; 51(3):199-206. PubMed ID: 5849058
    [No Abstract]   [Full Text] [Related]  

  • 52. [Thyroidfunctional exploration in patients with breast cancer].
    LENCIONI LJ; RICHIGER de ARRANZ E; DAVIDOVICH D; STAFFIERI JJ
    Medicina (B Aires); 1962; 22():215-21. PubMed ID: 13929595
    [No Abstract]   [Full Text] [Related]  

  • 53. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy.
    Giani C; Fierabracci P; Bonacci R; Gigliotti A; Campani D; De Negri F; Cecchetti D; Martino E; Pinchera A
    J Clin Endocrinol Metab; 1996 Mar; 81(3):990-4. PubMed ID: 8772562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis.
    Fang Y; Yao L; Sun J; Yang R; Chen Y; Tian J; Yang K; Tian L
    J Endocrinol Invest; 2017 Oct; 40(10):1035-1047. PubMed ID: 28516372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyroid function and survival following breast cancer.
    Brandt J; Borgquist S; Almquist M; Manjer J
    Br J Surg; 2016 Nov; 103(12):1649-1657. PubMed ID: 27599301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TSH receptor antibodies have predictive value for breast cancer - retrospective analysis.
    Szychta P; Szychta W; Gesing A; Lewiński A; Karbownik-Lewińska M
    Thyroid Res; 2013 May; 6(1):8. PubMed ID: 23680448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk.
    Tosovic A; Becker C; Bondeson AG; Bondeson L; Ericsson UB; Malm J; Manjer J
    Int J Cancer; 2012 Nov; 131(9):2126-33. PubMed ID: 22323002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical Significance of miR-155 and miR-375 as Diagnostic Biomarkers and Their Correlation with the NF-κβ/TNF-α Axis in Breast Cancer.
    Abdel-Samed SA; Hozyen WG; Shaaban SM; Hasona NA
    Indian J Clin Biochem; 2024 Apr; 39(2):226-232. PubMed ID: 38577133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-TPO antibody and thyroid hormone levels in Iranian female breast cancer patients and their association with prognostic factors: a case-control study.
    Ghahremanfard F; Jandaghi E; Ghobad R; Mirmohammadkhani M; Sarabi M
    Eur J Transl Myol; 2023 Mar; 33(1):. PubMed ID: 36924246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormonal Crosstalk Between Thyroid and Breast Cancer.
    Halada S; Casado-Medrano V; Baran JA; Lee J; Chinmay P; Bauer AJ; Franco AT
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35587175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.